Anticholinergic bronchodilators
https://themeditary.com/dosage-information/yupelri-dosage-1272.html

Yupelri Dosage

Drug Detail:Yupelri inhalation (Revefenacin (inhalation) [ rev-e-fen-a-sin ])

Generic Name: REVEFENACIN 175ug in 3mL

Dosage Form: inhalation solution

Drug Class: Anticholinergic bronchodilators

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

The recommended dosage is 175 mcg YUPELRI (one 175 mcg unit‑dose vial) administered by oral inhalation once daily by nebulizer using a mouthpiece.

Administration Overview

YUPELRI should be administered by the orally inhaled route via a standard jet nebulizer connected to an air compressor (See Instructions for Use). The safety and efficacy of YUPELRI have been established in clinical trials when administered using the PARI LC® Sprint nebulizer with a mouthpiece and the PARI Trek® S compressor. The safety and efficacy of YUPELRI delivered from non‑compressor based nebulizer systems have not been established.

The YUPELRI unit-dose vial should only be removed from the foil pouch and opened IMMEDIATELY BEFORE USE. The vial and any residual content should be discarded after use.

No dosage adjustment is required for geriatric patients, or patients with renal impairment [see Use in Specific Populations (8.5, 8.7) and Clinical Pharmacology (12.3)].

The drug compatibility (physical and chemical), efficacy, and safety of YUPELRI when mixed with other drugs in a nebulizer have not been established.

Share this Article
Latest News
Related Drugs